Researchers apply AOD9604 to investigate its selective activation of lipolytic processes in adipose tissue, observing upregulation of beta-3 adrenergic receptor-mediated fat oxidation. Pre-clinical findings in obese rodent models indicate promotion of lipid mobilization and improved metabolic parameters without influencing systemic IGF-1 levels or inducing significant anabolic responses.
This modified fragment facilitates examination of compartment-specific lipid handling, mitochondrial substrate utilization, and potential direct effects on chondrocyte function in cartilage-related research paradigms.
Scientific Overview of AOD9604 Applications
Pre-clinical models demonstrate AOD9604’s engagement with metabolic mechanisms:
- Stimulation of lipolysis through upregulation of beta-3 adrenergic receptors in adipose tissue, supporting fat oxidation in obese rodent systems. https://pubmed.ncbi.nlm.nih.gov/11146367/
- Reduction of body weight and adiposity without elevation of IGF-1 or broad growth-promoting activity in metabolic challenge models.
- Modulation of lipid profiles and energy substrate utilization in diet-induced obesity paradigms. https://pubmed.ncbi.nlm.nih.gov/11713213/
- Support for investigations into cartilage matrix synthesis and chondrocyte proliferation in osteoarthritis-related cell culture studies.
- Examination of metabolic safety profiles, including absence of diabetogenic or genotoxic effects in preclinical evaluations.
- Contribution to studies on selective fat compartment regulation and potential cartilage protective effects in joint tissue models.
For additional context on lipolytic fragments, beta-3 adrenergic signaling, and metabolic regulation in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs AOD9604
National Science Labs manufactures AOD9604 under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your AOD9604 Research Protocol
Source high-purity AOD9604 from current limited batches to ensure optimal stability and performance in lipolytic and metabolic regulation studies.
